Very true about margins. Learning a lot about investing from this precious Value pickr forum and from some amazing ppl like you here. I’m sure i’ll polish my brain even more for investing.
I don’t go for Technical analysing. Being from a legal field I have my limitations.
I buy and hold 25-30 stocks in my portfolio. Keep adding them on 8-10% when they go down or during market crash, if their fundamentals are still intact .
My idea is to stay invested in the market and cut yourself from the daily noise.
I don’t reshuffle my portfolio. I started investing two years back and till now sold only 2 stocks from my long term portfolio . Even that too to avoid duplication of stocks from same sector …
I like to hold all my stocks as much as i can …
Current PF. Removed Sparc, thanks to the suggestion from @sujay85 and added HCL, thanks to @Aniesh7 Still looking to add ITC, Sumitomo, Laurus Labs, Hindustan Copper (still studying), Bel, Navkar and want to increase stake in Bajaj consumer, Welspun Corp, Vidhi Speciality and in Happiest Minds.
Exited Expleo solution on Friday around cost price and will try to add around 450, if it comes in a week or two. As I mentioned earlier, today got a chance to add 33% quantity of ITC, 50% of Sumitomo. Will add more in further dips.
Current LT PF holdings. Added more quantity of Greaves Cotton during the fall to around 120 levels. Planning to add more sequent shares, if it comes around 245-250 levels, Suven pharma around 450-455 levels and Bajaj healthcare around 660 levels.
Exited Snowman logistics, Welspun Corp, Expleo Solutions and Suven pharma and added Jubilant Ingrevia, India Pesticides Limited and IEX instead.
Likely will offload ITC to add more Borosil Renewables and Sequent Scientific.
I’m still bullish on both. Exited Expleo around 1090 by an excitement mistake… Current mcap is around 1170Cr. I fully expect it to reach atleast 3-4k in the next 4-5 years, if managements walks the talk. Need to see how the new float of shares will cause impact on the share price. I’ll try to enter Expleo soon. Arranging some funds for it Suven pharma is one of my favorite businesses (CDMO) for a very long term option (10 years). But, from what i read and understood, in the next few years, earnings growth will be suppressed due to the maintenance capex they are doing. Switched that money to Jubilant Ingrevia as they are currently doing well. Basically opportunity cost switch. I’ll keep monitoring Suven pharma though.